跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AN-363
首页
药物
AN-363
AN-363
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
US 8513488 B2
申请人: EMMANUEL EYAL
优先权: 2008
US
5 件公开
ENGINEERED NUCLEASES AND COMPOSITIONS AND METHODS THEREOF
EP 4788806 A1
申请人: ACRIGEN BIOSCIENCES
优先权: 2023
CN
EP
WO
3 件公开
Induction of cross-reactive cellular response against rhinovirus antigens
US 9937252 B2
申请人: SANOFI PASTEUR
优先权: 2013
EP
US
3 件公开
Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder
US 6844432 B2
申请人: RIKEN
优先权: 2000
US
3 件公开
Antibodies to Nik, Their Preparation and Use
US 2008274102 A1
申请人: YEDA RES & DEV
优先权: 2003
US
Human Coagulation Factor VII Polypeptides
US 2009055942 A1
申请人: NOVO NORDISK HEALTHCARE AG
优先权: 2006
US
Rotavirus-resistant drug acting target, building method and application method thereof
CN 101863966 B
申请人: UNIV PLA 3RD MILITARY MEDICAL
优先权: 2010
CN
Ointment for curing scald and burn
CN 103127340 A
申请人: HUBEI AIMIN PHARMACEUTICAL CO LTD
优先权: 2011
CN
White spirit added with traditional Chinese medicines capable of tonifying Qi and yang
CN 108938884 A
申请人: WUWEI COUNTY HUAYUN WINE WORKSHOP CO LTD
优先权: 2018
CN
MUTANT ACE2 PROTEINS AND METHODS OF USING SAME
US 20250009853 A1
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2022
US
第 1 / 2 页
上一页
下一页
药物
反馈